The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

In a recent study published in the journal Frontiers in Immunology, researchers investigate the impact of dietary antigens in regulating small intestinal tumors. Despite being the most common type ...

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...

Boehringer Ingelheim has signed a strategic collaboration with UK biotech Enara Bio, focused on finding ways to fight cancer using “dark antigens” in a deal worth up to €876 million ($1.07bn).

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens from previously uncharted genomic dark matter. The round was led by ...

Approaches to therapy, both in cancer and in autoimmunity, can broadly be divided into the antigen-specific and the antigen-non-specific (Box 1). Each has its advantages and its drawbacks ...

A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current CA-125 thresholds ...

primary focus on cancer vaccines. The shot is the lead product candidate from BioNTech's FixVac platform and is based on a combination of four mRNA-encoded, melanoma-associated antigens – NY-ESO ...

Immunotherapy has revolutionized cancer treatment by harnessing the power of T cells ... alongside an equally vast number of potential antigen targets. Experimentally testing all these combinations is ...